Data on blood clots associated with the AstraZeneca vaccine
Data on blood clots associated with the AstraZeneca vaccine
This explainer is more than 90 days old. Some of the information might be out of date or no longer relevant. Browse our homepage for up to date content or request information about a specific topic from our team of scientists.
This article has been translated from its original language. Please reach out if you have any feedback on the translation.
The Winton Centre for Risk and Evidence Communication at the University of Cambridge in the UK has published updated graphics on the risks and benefits of the Oxford AstraZeneca vaccine and specific blood clots, in different age groups, and with different virus exposure levels, and also by gender.
The Winton Centre for Risk and Evidence Communication at the University of Cambridge in the UK has published updated graphics on the risks and benefits of the Oxford AstraZeneca vaccine and specific blood clots, in different age groups, and with different virus exposure levels, and also by gender.
